• Careers
  • Contact Us

Portola Pharmaceuticals

Discovering and developing novel therapeutics.

Menu

Skip to content
  • :About Us
    • :Leadership Team
    • :Board of Directors
    • :Scientific Advisory Board
    • :Translational Advisory Board
    • :Collaborations
    • :Business Development
  • :Product Pipeline
    • :Betrixaban: FXa Inhibitor
    • :PRT4445: FXa Inhibitor Antidote
    • :PRT2070: Dual Syk-JAK Inhibitor
    • :PRT2607: Syk-Specific Inhibitor
    • :Clinical Trials
    • :Publications
  • :Newsroom
  • :Investor Relations

Newsroom

We are committed to providing the media with timely and accurate information. Click here for news releases.

If you are a member of the media and have questions about company news announcements, interview requests or other related inquiries, please contact: 

Jani Bergan
BrewLife
415.946.1064
jbergan@brewlife.com 

News Releases

Online Media Kit

  • Corporate Fact Sheet

Publications

© 2013 Portola Pharmaceuticals, Inc. All rights reserved.
  •    Site Map
  •    Terms of Use
  •    Privacy Policy